YELLOWSTONE BIOSCIENCES

EUIPO EUIPO 2025 Application under examination

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark YELLOWSTONE BIOSCIENCES was filed as Word mark on 03/27/2025 at the European Union Intellectual Property Office. The current status of the mark is "Application under examination".

Trademark Details Last update: April 30, 2025

Trademark form Word mark
File reference 019163967
Application date March 27, 2025

Trademark owner

3rd Floor, 1 Ashley Road
WA14 2DT Altrincham
GB

Trademark representatives

19 boulevard Malesherbes 75008 Paris FR

goods and services

5 Pharmaceutical preparations and substances; immunotherapy preparations; pharmaceutical and biological preparations and substances for immunotherapy; therapeutic vaccines; genetic medicines; soluble T-cell receptor (TCT) based therapies; diagnostic reagents for medical purposes; synthetic peptides, proteins and cells for pharmaceutical purposes; peptides, proteins and cells for medical, diagnostic or therapeutic purposes; in vitro diagnostic reagents, in vivo diagnostic reagents, immunological reagents for medical use; biological reagents for medical/clinical diagnosis; diagnostic kits comprising reagents and medical diagnostic tests; biological reagents for medical research; biological reagents for medical use; biological preparations for medical use; immuno-therapeutic agents; antigen binding molecules, antibodies, antibody fragments, bi-specific T cell engagers (BiTEs), T cell receptors (TCRs) and chimeric antigen receptors (CARs); pharmaceutical preparations and substances for the treatment of cancer; biotechnological preparations for the treatment of cancer; immunotherapy preparations for the treatment of cancer; genetic medicines for the treatment of cancer; soluble T-cell receptor (TCR) based therapies for the treatment of cancer; immunotherapy products in oncology; preparation of therapeutic vaccines in oncology for human use; preparation of immunotherapy products in oncology for human use; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors; all of the aforesaid goods only for use in connection with immunotherapy
42 Scientific, medical and pharmaceutical research and development services in the field of immunotherapy; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services; biological research; clinical research; scientific research in the field of chemistry, biochemistry and biology; services of a biological, biochemical or chemical laboratory; performing of biological, biochemical or chemical analysis; cancer diagnostics for scientific purposes; biological and biochemical examination services; tests in laboratories; development of testing methods; research, development, technical design, testing, design and development of software in the field of biology; consultancy and analysis services in the field of immuno-therapeutics and in particular immune-oncology; Pharmaceutical product research and development; Biotechnology research and development; vaccine and immunotherapy research and development; research and development services in relation to pharmaceutical preparations and substances; research and development services in relation to pharmaceutical and biological preparations and substances for immunotherapy; research and development services in relation to gene therapy, cell therapy and genetic medicines; pharmaceutical and biological research and development services in connection with the treatment of cancer; research and development services in connection with gene therapy, cell therapy, genetic medicines and soluble T-cell receptor (TCR) based therapies for the treatment of cancer; advice, information and consultancy in connection with all of the aforesaid services; all of the aforesaid services only for use in connection with immunotherapy
44 Provision of medical information; Provision of medical information via a website; medical counselling and medical information relating to pharmaceuticals, immunotherapy, immune-therapeutic treatments, therapeutic vaccines and genetic medicines; services of a medical laboratory, providing medical supply for therapy, in particular supply of peptides, proteins or cells for immuno-therapy; medical diagnostics; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment by immune-therapeutics; medical and pharmaceutical consultancy; provision of medical information and services in the field of immuno-therapeutics; provision of medical treatment services and medical information services in relation to immuno-therapeutics

ID: 11019163967